Data / Drug companies / Hydroxyzine pamoate
Hydroxyzine pamoate: 30 companies and 82 products in the FDA NDC directory
Hydroxyzine pamoate is listed in the FDA National Drug Code Directory by 30 companies, with 82 products in commercial distribution. 82 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, and the newest product started marketing on July 8, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 30
- Products
- 82
- Generic (ANDA) products
- 82 (100.0%)
- Application numbers
- 7
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list hydroxyzine pamoate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 9 | capsule | Generic drugs (ANDA) | June 3, 2013 |
| NuCare Pharmaceuticals,Inc. | 5 | capsule | Generic drugs (ANDA) | June 3, 2013 |
| Proficient Rx LP | 5 | capsule | Generic drugs (ANDA) | June 3, 2013 |
| Remedyrepack Inc. | 5 | capsule | Generic drugs (ANDA) | August 30, 2025 |
| A-S Medication Solutions | 4 | capsule | Generic drugs (ANDA) | June 3, 2013 |
| Aphena Pharma Solutions - Tennessee, LLC | 4 | capsule | Generic drugs (ANDA) | June 3, 2013 |
| Unit Dose Solutions, Inc. | 4 | capsule | Generic drugs (ANDA) | July 8, 2026 |
| Asclemed USA, Inc. | 3 | capsule | Generic drugs (ANDA) | July 1, 1984 |
| Bryant Ranch Prepack | 3 | capsule | Generic drugs (ANDA) | July 1, 1984 |
| Coupler LLC | 3 | capsule | Generic drugs (ANDA) | June 16, 2026 |
| Direct_Rx | 3 | capsule | Generic drugs (ANDA) | May 30, 2023 |
| Northwind Health Company, LLC | 3 | capsule | Generic drugs (ANDA) | April 25, 2023 |
| Preferred Pharmaceuticals Inc. | 3 | capsule | Generic drugs (ANDA) | December 16, 2024 |
| Teva Pharmaceuticals USA, Inc. | 3 | capsule | Generic drugs (ANDA) | July 1, 1984 |
| American Health Packaging | 2 | capsule | Generic drugs (ANDA) | November 28, 2023 |
| Amneal Pharmaceuticals of New York LLC | 2 | capsule | Generic drugs (ANDA) | July 15, 1996 |
| AvPAK | 2 | capsule | Generic drugs (ANDA) | April 14, 2021 |
| Chartwell RX, LLC | 2 | capsule | Generic drugs (ANDA) | June 3, 2013 |
| Golden State Medical Supply, Inc. | 2 | capsule | Generic drugs (ANDA) | June 3, 2013 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 2 | capsule | Generic drugs (ANDA) | June 3, 2013 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | capsule | Generic drugs (ANDA) | July 15, 1996 |
| PD-Rx Pharmaceuticals, Inc. | 2 | capsule | Generic drugs (ANDA) | December 14, 1981 |
| Sandoz Inc | 2 | capsule | Generic drugs (ANDA) | December 14, 1981 |
| Bryant Ranch Prepack | 1 | capsule | Generic drugs (ANDA) | May 12, 2025 |
| Cardinal Health 107, LLC | 1 | capsule | Generic drugs (ANDA) | June 3, 2013 |
| Direct RX | 1 | capsule | Generic drugs (ANDA) | June 3, 2019 |
| Major Pharmaceuticals | 1 | capsule | Generic drugs (ANDA) | June 3, 2013 |
| Northwind Health Company, LLC | 1 | capsule | Generic drugs (ANDA) | February 19, 2024 |
| NuCare Pharmaceuticals, Inc. | 1 | capsule | Generic drugs (ANDA) | December 14, 1981 |
| Pharmasource Meds, LLC | 1 | capsule | Generic drugs (ANDA) | February 27, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 82 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 82 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Antihistamine | 82 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.